ESAB (NYSE:ESAB - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $1.28 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.15 by $0.13, Zacks reports. The company had revenue of $633.20 million for the quarter, compared to the consensus estimate of $636.43 million. ESAB had a return on equity of 17.27% and a net margin of 9.47%. ESAB updated its FY 2025 guidance to 5.100-5.250 EPS.
ESAB Stock Performance
Shares of ESAB stock traded down $0.04 during trading on Friday, hitting $120.07. The company's stock had a trading volume of 329,784 shares, compared to its average volume of 221,044. The company has a market cap of $7.26 billion, a PE ratio of 28.12, a P/E/G ratio of 2.02 and a beta of 1.36. The company has a current ratio of 1.92, a quick ratio of 1.25 and a debt-to-equity ratio of 0.58. The business has a fifty day moving average of $122.57 and a 200-day moving average of $115.61. ESAB has a 52 week low of $88.54 and a 52 week high of $135.97.
ESAB Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, January 17th. Stockholders of record on Tuesday, December 31st were issued a $0.08 dividend. This represents a $0.32 annualized dividend and a dividend yield of 0.27%. The ex-dividend date was Tuesday, December 31st. ESAB's dividend payout ratio is presently 7.41%.
Analyst Ratings Changes
ESAB has been the topic of a number of recent analyst reports. Evercore ISI downgraded ESAB from an "in-line" rating to an "underperform" rating and boosted their price objective for the company from $102.00 to $122.00 in a research note on Wednesday, November 13th. Loop Capital boosted their target price on ESAB from $105.00 to $120.00 and gave the company a "hold" rating in a research report on Wednesday, October 30th. Jefferies Financial Group assumed coverage on ESAB in a research report on Thursday, December 12th. They issued a "buy" rating and a $160.00 target price for the company. JPMorgan Chase & Co. decreased their target price on ESAB from $135.00 to $133.00 and set an "overweight" rating for the company in a research report on Friday. Finally, Oppenheimer reaffirmed an "outperform" rating and issued a $144.00 target price (up from $138.00) on shares of ESAB in a research report on Friday, November 8th. One research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, ESAB has an average rating of "Hold" and a consensus target price of $133.43.
Check Out Our Latest Stock Report on ESAB
ESAB Company Profile
(
Get Free Report)
ESAB Corporation engages in the formulation, development, manufacture, and supply of consumable products and equipment for use in cutting, joining, automated welding, and gas control equipment. Its comprehensive range of welding consumables includes electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables comprising electrodes, nozzles, shields, and tips.
Featured Articles

Before you consider ESAB, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ESAB wasn't on the list.
While ESAB currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.